Testosterone Enanthate
PubChem CID: 9416
Connections displayed (default: 10).
Loading graph...
| Compound Synonyms | testosterone enanthate, 315-37-7, Delatestryl, Androtardyl, Testosterone heptanoate, Testosterone enantate, Atlatest, Testanthate, Testinon, Testoenant, Everone, Testosterone heptylate, Exten test, Orquisteron-E, Depo-Testro Med, Andropository, Durathate, Testostroval, Testosterone heptoate, Reposo-TMD, Testosterone oenanthate, Testenate, DePatestrye, Malogen L.A., Testosterone 17-enanthate, Reposo TMD, Malogen L.A.200, NSC-17591, Testonenant, Testate, Xyosted, Ditate, 17-Hydroxyandrost-4-en-3-one, 17-heptanoate, Testosterone, heptanoate, Andro L.A. 200, Heptanoic acid, ester with testosterone, Testosterone ethanate, 17beta-Enanthoxyandrost-4-en-3-one, 4-Androsten-3-one 17beta-enanthate, 17-((1-Oxoheptyl)oxy)androst-4-en-3-one, CCRIS 7082, Delatest, Testosterone enanthate ciii, 17beta-Hydroxyandrost-4-en-3-one enanthate, EINECS 206-253-5, Androgyn L.A., Androst-4-en-3-one, 17-[(1-oxoheptyl)oxy]-, (17b)-, BRN 3170544, CHEBI:9464, UNII-7Z6522T8N9, Androst-4-en-3-one, 17-((1-oxoheptyl)oxy)-, (17beta)-, 7Z6522T8N9, Androst-4-en-3-one, 17beta-hydroxy-, heptanoate, Androst-4-en-3-one, 17-(1-oxoheptyl)oxy-, (17beta)-, Testosterone enanthate [USP:JAN], DTXSID701016540, 4-08-00-00979 (Beilstein Handbook Reference), NSC17591, [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate, 3-oxoandrost-4-en-17beta-yl heptanoate, 17beta-hydroxyandrost-4-en-3-one heptanoate, Testosterone 17-heptanoate, 17-heptanoyl-17beta-hydroxyandrost-4-en-3-one, DITATE-DS COMPONENT TESTOSTERONE ENANTHATE, Testosterone enanthate (USP:JAN), TESTOSTERONE ENANTATE (MART.), TESTOSTERONE ENANTATE [MART.], TESTOSTERONE ENANTHATE (USP-RS), TESTOSTERONE ENANTHATE [USP-RS], TESTOSTERONE ENANTATE (EP MONOGRAPH), TESTOSTERONE ENANTATE [EP MONOGRAPH], 17-[(1-Oxoheptyl)oxy]androst-4-en-3-one, TESTOSTERONE ENANTHATE CIII (USP-RS), TESTOSTERONE ENANTHATE CIII [USP-RS], TESTOSTERONE ENANTHATE (USP MONOGRAPH), TESTOSTERONE ENANTHATE [USP MONOGRAPH], Primosteston, Androst-4-en-3-one, 17-[(1-oxoheptyl)oxy]-, (17.beta.)-, Testo-Enant, Andro LA, Delatestryl (TN), Testosteroni enantas, Ditate (Salt/Mix), Xyosted (Autoinjector), Deladumone (Salt/Mix), Testosterone heptoic acid, SCHEMBL42687, Androgyn L.A. (Salt/Mix), Testosterone 17beta-heptanoate, CHEMBL1200335, Androst-4-en-3-one, heptanoate, DTXCID901474730, Testosterone 17beta-heptanoic acid, TESTOSTERONE ENANTHATE [MI], Testosterone enanthate (JP17/USP), TESTOSTERONE ENANTHATE [JAN], LMST02020075, s3717, Androst-4-en-3-one,(17.beta.)-, TESTOSTERONE ENANTHATE [VANDF], AKOS015960945, TESTOSTERONE ENANTATE [WHO-IP], CCG-268655, DB13944, TESTOSTERONE ENANTHATE [WHO-DD], 4-Androsten-3-one 17.beta.-enanthate, (8R,9S,10R,13S,14S,17S)-10,13-Dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl heptanoate, AC-12599, DS-11585, FT158490, Testosterone enanthate, analytical standard, 4-Androsten-17beta-ol-3-one 17-enanthate, TESTOSTERONE ENANTHATE [ORANGE BOOK], TESTOSTERONI ENANTAS [WHO-IP LATIN], NS00015428, WLN: L E5 B666 OV MUTJ A E FOV6, C08157, D00958, 17beta-(HEPTANOYLOXY)ANDROST-4-EN-3-ONE, 17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid, SR-01000942262, SR-01000942262-1, TESTOSTERONE ENANTHATE COMPONENT OF DITATE-DS, Androst-4-en-3-one, 17.beta.-hydroxy-, heptanoate, BRD-K89657519-001-01-8, Q27108402, 3-Oxoandrost-4-en-17-yl heptanoate, (17.beta.)- #, 17.BETA.-(HEPTANOYLOXY)ANDROST-4-EN-3-ONE [WHO-IP], 17- [(1- Oxoheptyl) oxy] - (17?) -androst- 4- en- 3- one, ANDROST-4-EN-3-ONE, 17-(1-OXOHEPTYL)OXY-, (17.BETA.)-, Testosterone enantate, European Pharmacopoeia (EP) Reference Standard, Testosterone enanthate, United States Pharmacopeia (USP) Reference Standard, Testosterone enantate for peak identification, European Pharmacopoeia (EP) Reference Standard, Testosterone enantate for system suitability, European Pharmacopoeia (EP) Reference Standard, 206-253-5 |
|---|---|
| Topological Polar Surface Area | 43.4 |
| Hydrogen Bond Donor Count | 0.0 |
| Heavy Atom Count | 29.0 |
| Description | testosterone enanthate is used in androgen substitution to replace testosterone at levels as close to physiological levels as is possible. For some androgen-dependent functions testosterone is a pro-hormone, peripherally converted to 5alpha-dihydrotestosterone (DHT) and 17beta-estradiol (E2), of which the levels preferably should be within normal physiological ranges. Furthermore, androgens should have a good safety profile without adverse effects on the prostate, serum lipids, liver or respiratory function, and they must be convenient to use and patient-friendly, with a relative independence from medical services. Natural testosterone is viewed as the best androgen for substitution in hypogonadal men. testosterone enanthate is used to treat male hypogonadism. Male hypogonadism is one of the most common endocrinologic syndromes. The diagnosis is based on clinical signs and symptoms plus laboratory confirmation via the measurement of low morning testosterone levels on two different occasions. Serum luteinizing hormone and follicle-stimulating hormone levels distinguish between primary (hypergonadotropic) and secondary (hypogonadotropic) hypogonadism. Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism. In primary hypogonadal men the on bone mineral density (BMD) responds dose dependently to testosterone substitution, whereas in secondary hypogonadism only testosterone enanthate treatment significantly increased the BMD. In all mammalian species studied to date, testosterone has been found to be the predominant intratesticular steroid. In volunteers receiving hormonal contraception by using a combination of testosterone enanthate and levonorgestrel, there is a profound reduction of both intratesticular testosterone concentration and androgen bioactivity. High doses of testosterone enanthate can normalize hematocrit values of maintenance hemodialysis patients with replenished bone marrow iron stores. testosterone enanthate is classified as a prohibited substance by the World Anti-Doping Agency (WADA) and its use may be detected by way of the urinary testosterone/epitestosterone (T/E) ratio. (PMID: 16185098, 16467270, 15329035, 17530941, 17484401, 4028529, 12792150) [HMDB] |
| Isotope Atom Count | 0.0 |
| Molecular Complexity | 679.0 |
| Database Name | cmaup_ingredients;fooddb_chem_all;pubchem |
| Defined Atom Stereocenter Count | 6.0 |
| Iupac Name | [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate |
| Prediction Hob | 0.0 |
| Class | Steroids and steroid derivatives |
| Xlogp | 6.3 |
| Superclass | Lipids and lipid-like molecules |
| Subclass | Steroid esters |
| Molecular Formula | C26H40O3 |
| Prediction Swissadme | 0.0 |
| Inchi Key | VOCBWIIFXDYGNZ-IXKNJLPQSA-N |
| Fcsp3 | 0.8461538461538461 |
| Rotatable Bond Count | 7.0 |
| State | Solid |
| Synonyms | 17-((1-Oxoheptyl)oxy)androst-4-en-3-one, 17-Hydroxyandrost-4-en-3-one, 17-heptanoate, 17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid, 17b-Hydroxyandrost-4-en-3-one heptanoate, 17b-Hydroxyandrost-4-en-3-one heptanoic acid, 17beta-Enanthoxyandrost-4-en-3-one, 17beta-Hydroxyandrost-4-en-3-one enanthate, 17beta-Hydroxyandrost-4-en-3-one heptanoate, 17beta-Hydroxyandrost-4-en-3-one heptanoic acid, 17β-hydroxyandrost-4-en-3-one heptanoate, 17β-hydroxyandrost-4-en-3-one heptanoic acid, 4-Androsten-17beta-ol-3-one 17-enanthate, 4-Androsten-3-one 17beta-enanthate, Androgyn L.A., Andropository, Androtardyl, Atlatest, DEA No. 4000, Delatest, Delatestryl, DePatestrye, Depo-Testro Med, Ditate, Durathate, Everone, Exten test, Malogen L.A., Malogen L.A.200, Orquisteron-E, Primotestone, Reposo TMD, Testanthate, Testate, Testenate, Testinon, Testoenant, Testonenant, Testosterone 17-enanthate, Testosterone 17-enanthic acid, Testosterone 17beta-heptanoate, Testosterone 17beta-heptanoic acid, Testosterone enantate, Testosterone heptanoate, Testosterone heptanoic acid, Testosterone heptoate, Testosterone heptoic acid, Testosterone heptylate, Testosterone oenanthate, Testostroval |
| Substituent Name | Steroid ester, Androgen-skeleton, Androstane-skeleton, Oxosteroid, 3-oxosteroid, 3-oxo-delta-4-steroid, Delta-4-steroid, Cyclic ketone, Ketone, Carboxylic acid ester, Monocarboxylic acid or derivatives, Ether, Carboxylic acid derivative, Hydrocarbon derivative, Organooxygen compound, Carbonyl group, Aliphatic homopolycyclic compound |
| Compound Name | Testosterone Enanthate |
| Kingdom | Organic compounds |
| Prediction Hob Swissadme | 0.0 |
| Exact Mass | 400.298 |
| Formal Charge | 0.0 |
| Monoisotopic Mass | 400.298 |
| Hydrogen Bond Acceptor Count | 3.0 |
| Molecular Weight | 400.6 |
| Covalent Unit Count | 1.0 |
| Total Atom Stereocenter Count | 6.0 |
| Total Bond Stereocenter Count | 0.0 |
| Esol | -5.862238600000001 |
| Inchi | InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1 |
| Smiles | CCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C |
| Defined Bond Stereocenter Count | 0.0 |
- 1. Outgoing r'ship
FOUND_INto/from Chaenomeles Sinensis (Plant) Rel Props:Source_db:cmaup_ingredients - 2. Outgoing r'ship
FOUND_INto/from Thlaspi Arvense (Plant) Rel Props:Source_db:cmaup_ingredients